Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data.

Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M.

Crit Care Explor. 2019 Oct 14;1(10):e0049. doi: 10.1097/CCE.0000000000000049. eCollection 2019 Oct.

2.

Estimation of the burden of bacteriologically positive Tuberculosis among Adults in Kashmir: A baseline for future surveys in the Valley.

Ur-Rehman S, Kausar R, Kadri SM, Jan N, Bhat B, Najar S, Chattu VK.

J Family Med Prim Care. 2020 Jan 28;9(1):56-60. doi: 10.4103/jfmpc.jfmpc_179_19. eCollection 2020 Jan.

3.

Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.

Strich JR, Ricotta E, Warner S, Lai YL, Demirkale CY, Hohmann SF, Rhee C, Klompas M, Palmore T, Powers JH, Dekker JP, Adjemian J, Matsouaka R, Woods CW, Danner RL, Kadri SS.

Clin Infect Dis. 2020 Feb 28. pii: ciaa061. doi: 10.1093/cid/ciaa061. [Epub ahead of print]

PMID:
32107536
4.

Cytosponge™ for post-chemoradiation surveillance of oesophageal cancer: a feasibility study.

Levy S, Moschandreas J, Debiram-Beecham I, O'Donovan M, Brooks C, Bailey A, Hawkins M, Kadri S, de Caestecker J, Crosby T, Fitzgerald R, Mukherjee S.

Ann Oncol. 2019 Jul;30 Suppl 4:iv57. doi: 10.1093/annonc/mdz155.209. Epub 2019 Dec 4. No abstract available.

PMID:
32085213
5.

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.

Cahill KE, Karimi YH, Karrison TG, Jain N, Green M, Weiner H, Fulton N, Kadri S, Godley LA, Artz AS, Liu H, Thirman MJ, Le Beau MM, McNerney ME, Segal J, Larson RA, Stock W, Odenike O.

Blood Adv. 2020 Feb 25;4(4):599-606. doi: 10.1182/bloodadvances.2019000795.

6.

Preventive and curative effects of grape seed powder on stroke using in vitro and in vivo models of cerebral ischemia/reperfusion.

Kadri S, El Ayed M, Limam F, Aouani E, Mokni M.

Biomed Pharmacother. 2020 May;125:109990. doi: 10.1016/j.biopha.2020.109990. Epub 2020 Feb 25.

7.

Predicting Sepsis Mortality and Costs Using Medicare Claims: A Method to the Madness.

Busch LM, Kalil AC, Kadri SS.

Crit Care Med. 2020 Mar;48(3):424-426. doi: 10.1097/CCM.0000000000004227. No abstract available.

PMID:
32058378
8.

Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas.

Setia N, Wanjari P, Yassan L, Niu N, Kadri S, Ritterhouse L, Misdraji J, Brown I, Segal J, Hart J.

Hum Pathol. 2020 Mar;97:103-111. doi: 10.1016/j.humpath.2019.11.004. Epub 2019 Nov 27.

PMID:
31783043
9.

Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing.

Ritterhouse LL, Parilla M, Zhen CJ, Wurst MN, Puranik R, Henderson CM, Joudeh NZ, Hartley MJ, Haridas R, Wanjari P, Furtado LV, Kadri S, Segal JP.

Mol Diagn Ther. 2019 Dec;23(6):791-802. doi: 10.1007/s40291-019-00436-8.

PMID:
31673932
10.

Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.

Balagopal V, Hantel A, Kadri S, Steinhardt G, Zhen CJ, Kang W, Wanjari P, Ritterhouse LL, Stock W, Segal JP.

PLoS One. 2019 Oct 28;14(10):e0224097. doi: 10.1371/journal.pone.0224097. eCollection 2019.

11.

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center.

Choudhury NJ, Eghtesad M, Kadri S, Cursio J, Ritterhouse L, Segal J, Husain A, Patel JD.

Oncotarget. 2019 Oct 8;10(56):5817-5823. doi: 10.18632/oncotarget.27212. eCollection 2019 Oct 8.

12.

A Reappraisal of Streptococcal Urinary Antigen Testing for Antibiotic Stewardship.

Kadri SS.

Clin Infect Dis. 2019 Oct 7. pii: ciz989. doi: 10.1093/cid/ciz989. [Epub ahead of print] No abstract available.

PMID:
31587033
13.

Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and Treatment.

Strich JR, Kadri SS.

Semin Respir Crit Care Med. 2019 Aug;40(4):419-434. doi: 10.1055/s-0039-1696662. Epub 2019 Oct 4.

PMID:
31585469
14.

[Epidemiological, clinical and evolutionary profile of patients with tuberculosis at the Regional Hospital of Maradi, Republic of the Niger].

Amadou MLH, Abdoulaye O, Amadou O, Biraïma A, Kadri S, Amoussa AAK, Lawan IM, Tari L, Daou M, Brah S, Adehossi E.

Pan Afr Med J. 2019 Jun 17;33:120. doi: 10.11604/pamj.2019.33.120.17715. eCollection 2019. French.

15.

A polypoidal 'non-polyp' in the colon.

McGoran JJ, Kadri SR, Moreman C, Wurm P.

Gut. 2019 Aug 20. pii: gutjnl-2019-319581. doi: 10.1136/gutjnl-2019-319581. [Epub ahead of print] No abstract available.

PMID:
31431467
16.

The authors reply.

Pepper DJ, Kadri SS.

Crit Care Med. 2019 Sep;47(9):e790-e791. doi: 10.1097/CCM.0000000000003875. No abstract available.

PMID:
31415326
17.

Unusual cystic lesion adjacent to the stomach.

McGoran JJ, Mullineux JH, Sutton CD, Kadri SR.

Gut. 2019 Jul 29. pii: gutjnl-2019-318823. doi: 10.1136/gutjnl-2019-318823. [Epub ahead of print] No abstract available.

PMID:
31358577
18.

External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals.

Kadri SS, Lai YLE, Ricotta EE, Strich JR, Babiker A, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Danner RL, Adjemian J; NIH Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI).

Open Forum Infect Dis. 2019 Feb 28;6(4):ofz110. doi: 10.1093/ofid/ofz110. eCollection 2019 Apr.

19.

Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma.

Chapel DB, Patil SA, Plagov A, Puranik R, Mendybaeva A, Steinhardt G, Wanjari P, Lastra RR, Kadri S, Segal JP, Ritterhouse LL.

Mod Pathol. 2019 Oct;32(10):1508-1520. doi: 10.1038/s41379-019-0298-5. Epub 2019 Jun 11.

PMID:
31186530
20.

Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data.

Rhee C, Wang R, Zhang Z, Fram D, Kadri SS, Klompas M; CDC Prevention Epicenters Program.

Crit Care Med. 2019 Sep;47(9):1169-1176. doi: 10.1097/CCM.0000000000003817.

PMID:
31135503
21.

Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.

Alpert L, Yassan L, Poon R, Kadri S, Niu N, Patil SA, Mujacic I, Montes D, Galbo F, Wurst MN, Zhen CJ, Cohen RD, Rubin DT, Pekow JR, Weber CR, Xiao SY, Hart J, Segal J, Setia N.

Hum Pathol. 2019 Jul;89:44-50. doi: 10.1016/j.humpath.2019.04.013. Epub 2019 May 2.

PMID:
31054900
22.

Distribution and relative densities of Aedes aegypti in Niger.

Labbo R, Doumma A, Mahamadou I, Arzika I, Soumana A, Kadri S, Idi I, Testa J.

Med Sante Trop. 2019 Feb 1;29(1):47-54. doi: 10.1684/mst.2019.0882.

23.

Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma.

Parilla M, Alikhan M, Al-Kawaaz M, Patil S, Kadri S, Ritterhouse LL, Segal J, Fitzpatrick C, Antic T.

Am J Surg Pathol. 2019 Aug;43(8):1135-1144. doi: 10.1097/PAS.0000000000001255.

PMID:
30986793
24.

Epidemiology of Quick Sequential Organ Failure Assessment Criteria in Undifferentiated Patients and Association With Suspected Infection and Sepsis.

Anand V, Zhang Z, Kadri SS, Klompas M, Rhee C; CDC Prevention Epicenters Program.

Chest. 2019 Aug;156(2):289-297. doi: 10.1016/j.chest.2019.03.032. Epub 2019 Apr 9.

PMID:
30978329
25.

Dwindling Utilization of Central Venous Catheter Tip Cultures: An Analysis of Sampling Trends and Clinical Utility at 128 US Hospitals, 2009-2014.

Lai YL, Adjemian J, Ricotta EE, Mathew L, O'Grady NP, Kadri SS.

Clin Infect Dis. 2019 Oct 30;69(10):1797-1800. doi: 10.1093/cid/ciz218.

26.

Hepatitis A and E Outbreak Surveillance during 2015-2017 in Kashmir, India: Is the Water to Blame?

Kadri SM, Rehman SU, Rehana K, Benetou DR, Ahmad DF, Abdullah A, Chattu VK.

J Epidemiol Glob Health. 2018 Dec;8(3-4):203-207. doi: 10.2991/j.jegh.2018.04.101.

PMID:
30864764
27.

Reply to Raoult and Rolain, and to Echols and Tillotson.

Kadri SS, Danner RL.

Clin Infect Dis. 2019 Oct 15;69(9):1642-1644. doi: 10.1093/cid/ciz186. No abstract available.

28.

Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.

Kadri SS, Strich JR, Swihart BJ, Hohmann S, Dekker JP, Palmore T, Bonne S, Freeman B, Raybould J, Shah NG, Patel D, Husson J, Jacobs MD, Duong L, Follmann D, Hooper DC, Timpone J, Danner RL.

Am J Infect Control. 2019 Sep;47(9):1040-1047. doi: 10.1016/j.ajic.2019.01.010. Epub 2019 Feb 27.

PMID:
30824387
29.

Neuroprotective effect of grape seed extract on brain ischemia: a proteomic approach.

Kadri S, El Ayed M, Cosette P, Jouenne T, Elkhaoui S, Zekri S, Limam F, Aouani E, Mokni M.

Metab Brain Dis. 2019 Jun;34(3):889-907. doi: 10.1007/s11011-019-00396-2. Epub 2019 Feb 22.

PMID:
30796716
30.

Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients.

Pepper DJ, Demirkale CY, Sun J, Rhee C, Fram D, Eichacker P, Klompas M, Suffredini AF, Kadri SS.

Crit Care Med. 2019 May;47(5):643-650. doi: 10.1097/CCM.0000000000003692.

PMID:
30789403
31.

Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis.

Pepper DJ, Sun J, Rhee C, Welsh J, Powers JH 3rd, Danner RL, Kadri SS.

Chest. 2019 Jun;155(6):1109-1118. doi: 10.1016/j.chest.2018.12.029. Epub 2019 Feb 14.

PMID:
30772386
32.

Sepsis Surveillance Using Adult Sepsis Events Simplified eSOFA Criteria Versus Sepsis-3 Sequential Organ Failure Assessment Criteria.

Rhee C, Zhang Z, Kadri SS, Murphy DJ, Martin GS, Overton E, Seymour CW, Angus DC, Dantes R, Epstein L, Fram D, Schaaf R, Wang R, Klompas M; CDC Prevention Epicenters Program.

Crit Care Med. 2019 Mar;47(3):307-314. doi: 10.1097/CCM.0000000000003521.

33.

Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.

Parilla M, Kadri S, Patil SA, Fitzpatrick C, Ritterhouse L, Segal J, Collins J, Pytel P.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):257-267. doi: 10.1093/jnen/nly130.

PMID:
30698790
34.

Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.

Haas NB, Appleman LJ, Stein M, Redlinger M, Wilks M, Xu X, Onorati A, Kalavacharla A, Kim T, Zhen CJ, Kadri S, Segal JP, Gimotty PA, Davis LE, Amaravadi RK.

Clin Cancer Res. 2019 Apr 1;25(7):2080-2087. doi: 10.1158/1078-0432.CCR-18-2204. Epub 2019 Jan 11.

35.

Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis.

Cracolici V, Kadri S, Ritterhouse LL, Segal JP, Wanjari P, Cipriani NA.

Am J Surg Pathol. 2019 Apr;43(4):514-522. doi: 10.1097/PAS.0000000000001208.

PMID:
30557173
36.

XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB.

Ming M, Wu W, Xie B, Sukhanova M, Wang W, Kadri S, Sharma S, Lee J, Shacham S, Landesman Y, Maltsev N, Lu P, Wang YL.

Mol Cancer Ther. 2018 Dec;17(12):2564-2574. doi: 10.1158/1535-7163.MCT-17-0789-ATR.

37.

Central Venous Catheter Failures: Nowhere Near Zero.

O'Grady NP, Kadri SS.

Crit Care Med. 2018 Dec;46(12):2054-2056. doi: 10.1097/CCM.0000000000003479. No abstract available.

38.

Characterization, anti-oxidative effect of grape seed powder and in silico affinity profiling of polyphenolic and extra-phenolic compounds for calpain inhibition.

Kadri S, El Ayed M, Mabrouk M, Limam F, Elkahoui S, Aouani E, Mokni M.

J Pharm Biomed Anal. 2019 Feb 5;164:365-372. doi: 10.1016/j.jpba.2018.11.003. Epub 2018 Nov 3.

PMID:
30439664
39.

Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons.

Rhee C, Jentzsch MS, Kadri SS, Seymour CW, Angus DC, Murphy DJ, Martin GS, Dantes RB, Epstein L, Fiore AE, Jernigan JA, Danner RL, Warren DK, Septimus EJ, Hickok J, Poland RE, Jin R, Fram D, Schaaf R, Wang R, Klompas M; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program.

Crit Care Med. 2019 Apr;47(4):493-500. doi: 10.1097/CCM.0000000000003554.

PMID:
30431493
40.

Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.

Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR.

Nat Commun. 2018 Nov 13;9(1):4827. doi: 10.1038/s41467-018-07303-w.

41.

Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.

Coffey GP, Feng J, Betz A, Pandey A, Birrell M, Leeds JM, Der K, Kadri S, Lu P, Segal J, Wang YL, Michelson G, Curnutte JT, Conley PB.

Clin Cancer Res. 2019 Feb 15;25(4):1174-1184. doi: 10.1158/1078-0432.CCR-18-1047. Epub 2018 Oct 17.

42.

insiM: in silico Mutator Software for Bioinformatics Pipeline Validation of Clinical Next-Generation Sequencing Assays.

Patil SA, Mujacic I, Ritterhouse LL, Segal JP, Kadri S.

J Mol Diagn. 2019 Jan;21(1):19-26. doi: 10.1016/j.jmoldx.2018.08.001. Epub 2018 Sep 29.

43.

Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.

Corean J, Furtado LV, Kadri S, Segal JP, Emerson LL.

Int J Surg Pathol. 2019 May;27(3):294-304. doi: 10.1177/1066896918796946. Epub 2018 Sep 3.

PMID:
30176755
44.

Large Aneurysm in Renal Angiomyolipoma.

Khan AA, Saquib S, Hafeez R, Kadri S.

J Coll Physicians Surg Pak. 2018 Sep;28(9):S160-S161. doi: 10.29271/jcpsp.2018.09.S160.

PMID:
30173683
45.

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE.

J Clin Oncol. 2018 Oct 1;36(28):2863-2871. doi: 10.1200/JCO.2018.78.5204. Epub 2018 Aug 16.

46.

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.

Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):647-656.e1. doi: 10.1016/j.cgh.2018.07.043. Epub 2018 Aug 9.

47.

Should Mumps Be Higher Up on the Public Health Agenda in India? A Concern for Global Health Security.

Kadri SM, Rehman SU, Rehana K, Brady AH, Chattu VK.

Med Sci (Basel). 2018 Aug 7;6(3). pii: E62. doi: 10.3390/medsci6030062.

48.

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.

Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI).

Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378.

49.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.

PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.

50.

Recognizing the Unique Role of Critical Care Providers in Confronting Antimicrobial Resistance.

Kadri SS.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):560-562. doi: 10.1164/rccm.201805-0962ED. No abstract available.

Supplemental Content

Support Center